Abstract
Although patients with Fanconi’s anaemia (FA) exhibit a heightened sensitivity to DNA cross-linking agents, modified doses of CY continue to be used in their conditioning prior to BMT. We measured the pharmacokinetics and metabolism of CY in six children with FA using an established high performance thin layer chromatography technique. CY doses ranged between 5 and 20 mg/kg (median 10 mg/kg). The median CY clearance was 0.6 l/h/m2 (range 0.4–1.1 l/h/m2), t1/2 was 8.1 h (range 6.7–9.5 h) and volume of distribution was 0.19 l/kg (range 0.16–0.34 l/kg), respectively. These results contrast with those previously reported from a comparable group of non-FA children in whom the median CY clearance was 3.2 l/h/m2 (range 2–5 l/h/m2) (P = 0.035), t1/2 was 2.4 h (range 2–3.8 h) (P = 0.035) and volume of distribution 0.5 l/kg (range 0.26–0.95 l/kg) (NS). Unlike the control group in whom the presence of inactive metabolites of CY was common, metabolites could not be found in any FA patient. The enhanced sensitivity of children with FA to CY may in part result from altered drug metabolism.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yule, S., Price, L., Cole, M. et al. Cyclophosphamide metabolism in children with Fanconi’s anaemia. Bone Marrow Transplant 24, 123–128 (1999). https://doi.org/10.1038/sj.bmt.1701868
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1701868
Keywords
This article is cited by
-
Population pharmacokinetics of cyclophosphamide in patients with thalassemia major undergoing HSCT
Bone Marrow Transplantation (2012)